赤子城科技(9911.HK)與騰訊控股達成戰略合作,赤子城商業化將獲騰訊加持
格隆匯4月28日丨赤子城科技(9911.HK)發佈公吿,宣佈與騰訊控股建立戰略合作關係,騰訊將為赤子城科技的流量變現提供支持。據悉,本次合作將為赤子城科技帶來至少數億元人民幣的收入。公司在公吿中稱:“與騰訊控股的合作可以加速本集團產品的市場拓展。”赤子城科技2013年開始拓展海外業務,目前專注於社交出海領域,旗下多款音視頻社交產品在中東、東南亞、南亞、北美等地廣受歡迎。2021年第一季度,公司社交產品平均月活約為1658萬,環比增長25.75%;整體收入預期為5.04~5.44億元,同比增長超470%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.